Pennant Reports Third Quarter 2024 Results

Rhea-AI Summary

Pennant Group (NASDAQ: PNTG) reported strong Q3 2024 results with total revenue of $180.7 million, up 28.9% year-over-year. Net income reached $6.2 million, increasing 41.6%, while adjusted earnings per share was $0.26. Home Health and Hospice Services segment revenue grew 33.7% to $135.7 million, with total home health admissions up 38.5%. Senior Living Services segment revenue increased 16.3% to $45.0 million. The company updated its 2024 guidance, projecting total revenue between $665.3-706.5 million and adjusted earnings per share of $0.90-0.96.

Positive

• Revenue increased 28.9% YoY to $180.7 million
• Net income grew 41.6% YoY to $6.2 million
• Home Health admissions increased 38.5% to 14,993
• Hospice average daily census grew 27.7%
• Senior Living segment revenue up 16.3% with 7.8% higher monthly revenue per room

Negative

• Senior Living occupancy remains relatively low at 79.1%, with minimal improvement of 20 basis points YoY

Insights

Financial Analyst

Strong Q3 2024 results demonstrate robust growth across key metrics. $180.7M total revenue represents a significant 28.9% YoY increase, while net income grew 41.6% to $6.2M. Home Health and Hospice segment shows particularly impressive performance with 33.7% revenue growth to $135.7M.

The company's operational efficiency is evident in the 39.2% increase in Adjusted EBITDA to $15.1M. Strong admission growth in home health (38.5%) and hospice census expansion (27.7%) indicate successful market penetration and execution of growth strategies.

Updated guidance range of $665.3M to $706.5M in revenue and adjusted EPS of $0.90 to $0.96 suggests continued momentum. Recent equity offering and expanded credit facility provide financial flexibility for future acquisitions and growth initiatives.

Healthcare Services Analyst

Operational metrics show strong market positioning in both core segments. Home Health and Hospice services demonstrate exceptional growth with total admissions up 38.5% and Medicare admissions increasing 30.8%. The hospice average daily census growth of 27.7% indicates successful patient acquisition and retention strategies.

Senior Living segment shows steady improvement with occupancy at 79.1% and monthly revenue per occupied room increasing 7.8% to $4,836. The segment's adjusted EBITDAR growth of 16.9% suggests effective cost management and pricing strategies despite industry-wide staffing challenges.

Conference Call and Webcast scheduled for tomorrow, November 7, 2024 at 10:00 am MT

EAGLE, Idaho, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the third quarter of 2024, reporting GAAP diluted earnings per share of $0.20 for the third quarter of 2024. Pennant also reported adjusted diluted earnings per share of $0.26 for the quarter ⁽¹⁾.

Third Quarter Highlights

• Total revenue for the third quarter was $180.7 million, an increase of $40.5 million or 28.9% over the prior year quarter;

• Net income for the third quarter was $6.2 million, an increase of $1.8 million or 41.6% over the prior year quarter;

• Adjusted net income for the third quarter was $8.2 million, an increase of $2.2 million or 36.8% over the prior year quarter;

• Segment Adjusted EBITDAR from Operations for the third quarter was $26.0 million, an increase of $5.4 million or 25.9% over the prior year quarter;

• Adjusted EBITDA for the third quarter was $15.1 million, an increase of $4.3 million or 39.2% over the prior year quarter;

• Home Health and Hospice Services segment revenue for the third quarter was $135.7 million, an increase of $34.2 million or 33.7% over the prior year quarter;

• Home Health and Hospice Services segment adjusted EBITDAR from operations for the third quarter was $23.7 million, an increase of $6.5 million or 37.4% over the prior year quarter; and segment adjusted EBITDA from operations the third quarter was $21.9 million, an increase of $6.0 million or 37.5% over the prior year quarter;

• Total home health admissions for the third quarter were 14,993, an increase of 4,164 or 38.5% over the prior year quarter; total Medicare home health admissions for the third quarter were 6,071, an increase of 1,431 or 30.8% over the prior year quarter;

• Hospice average daily census for the third quarter was 3,444, an increase of 746 or 27.7% compared to the prior year quarter;

• Senior Living Services segment revenue for the third quarter was $45.0 million, an increase of $6.3 million or 16.3% over the prior year quarter; average occupancy for the third quarter was 79.1%, an increase of 20 basis points over the prior year quarter, and average monthly revenue per occupied room for the third quarter was $4,836 an increase of $350 or 7.8% over the prior year quarter;

• Senior Living segment adjusted EBITDAR from operations for the third quarter was $13.4 million, an increase of $1.9 million or 16.9% over the prior year quarter; and segment adjusted EBITDA from Operations for the third quarter was $4.4 million, an increase of $1.3 million or 43.8% over the prior year quarter.

(1	)		See "Reconciliation of GAAP to Non-GAAP Financial Information.”

Operating Results

“Our strong third quarter financial results demonstrate the momentum we are building across the business, and we are pleased to see robust performance in our existing operations even as we integrate new ones. The equity offering we executed after quarter end, coupled with the expansion of our revolving credit facility during the quarter, position us exceptionally well for future growth. With these operating results and a healthy balance sheet, we are poised for success through the remainder of 2024 and beyond,” said Brent Guerisoli, the Company’s Chief Executive Officer.

A discussion of the Company's use of Non-GAAP financial measures is set forth below. A reconciliation of net income to EBITDA, adjusted EBITDAR and adjusted EBITDA, as well as a reconciliation of GAAP earnings per share, net income to adjusted net earnings per share and adjusted net income, appear in the financial data portion of this release. More complete information is contained in the Company’s Form 10-Q for the three and nine months ended September 30, 2024, which has been filed with the SEC today and can be viewed on the Company’s website at www.pennantgroup.com.

2024 Guidance

Management is updating its annual guidance as follows: total revenue is anticipated to be between $665.3 million and $706.5 million; full year 2024 adjusted earnings per diluted share is anticipated to be between $0.90 and $0.96; and full year 2024 adjusted EBITDA is anticipated to be between $51.9 million and $55.2 million.

“The Company’s updated guidance reflects the continued momentum in the business, and incorporates current operations and organic growth, diluted weighted average shares outstanding of approximately 32.5 million, and a 26.0% effective tax rate,” stated Lynette Walbom, Pennant’s Chief Financial Officer. “It anticipates consistent operating performance through the end of the year, hospice reimbursement rate adjustments, decreased interest expense, and contributions from our joint ventures and management agreements. It excludes unannounced acquisitions, the announced purchase of Signature’s Oregon assets, start-ups, share-based compensation, acquisition-related costs, or one-time implementation and unusual items.”

Conference Call

A live webcast will be held tomorrow, November 7, 2024 at 10:00 a.m. Mountain time (12:00 p.m. Eastern time) to discuss Pennant’s third quarter 2024 financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors Relations section of Pennant’s website at https://investor.pennantgroup.com. The webcast will be recorded and will be available for replay via the website.

About Pennant

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 122 home health and hospice agencies and 54 senior living communities located throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the company’s periodic filings with the Securities and Exchange Commission, including its Form 10-Q and/or 10-K, for a more complete discussion of the risks and other factors that could affect Pennant’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Pennant does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Contact Information

Investor Relations
The Pennant Group, Inc.
(208) 506-6100
ir@pennantgroup.com

SOURCE: The Pennant Group, Inc.

THE PENNANT GROUP, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (unaudited, in thousands, except for per-share amounts)
	Three Months Ended September 30,								Nine Months Ended September 30,
		2024				2023				2024				2023
Revenue	$	180,688			$	140,192			$	506,348			$	398,937
Expense
Cost of services		144,468				112,384				405,776				321,162
Rent—cost of services		10,906				10,006				31,814				29,439
General and administrative expense		13,023				9,417				36,337				26,913
Depreciation and amortization		1,493				1,323				4,292				3,817
Loss (gain) on disposition of property and equipment, net		4				1				(751	)			4
Total expenses		169,894				133,131				477,468				381,335
Income from operations		10,794				7,061				28,880				17,602
Other (expense) income, net:
Other income (expense)		109				(37	)			192				28
Interest expense, net		(2,892	)			(1,496	)			(6,306	)			(4,355	)
Other expense, net		(2,783	)			(1,533	)			(6,114	)			(4,327	)
Income before provision for income taxes		8,011				5,528				22,766				13,275
Provision for income taxes		1,354				1,066				4,957				3,894
Net income		6,657				4,462				17,809				9,381
Less: Net income attributable to noncontrolling interest		452				79				1,008				351
Net income attributable to The Pennant Group, Inc.	$	6,205			$	4,383			$	16,801			$	9,030
Earnings per share:
Basic	$	0.20			$	0.15			$	0.56			$	0.30
Diluted	$	0.20			$	0.15			$	0.54			$	0.30
Weighted average common shares outstanding:
Basic		30,281				29,912				30,157				29,825
Diluted		31,363				30,206				30,869				30,178

THE PENNANT GROUP, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except par value)
	September 30, 2024				December 31, 2023
Assets
Current assets:
Cash	$	4,464			$	6,059
Accounts receivable—less allowance for doubtful accounts of $313 and $259, respectively		84,025				61,116
Prepaid expenses and other current assets		13,307				12,902
Total current assets		101,796				80,077
Property and equipment, net		41,865				28,598
Right-of-use assets		265,441				262,923
Deferred tax assets, net		245				—
Restricted and other assets		12,173				9,337
Goodwill		129,337				91,014
Other indefinite-lived intangibles		95,902				67,742
Total assets	$	646,759			$	539,691
Liabilities and equity
Current liabilities:
Accounts payable	$	15,888			$	10,841
Accrued wages and related liabilities		36,565				28,256
Operating lease liabilities—current		19,113				17,122
Other accrued liabilities		19,029				15,330
Total current liabilities		90,595				71,549
Long-term operating lease liabilities—less current portion		248,907				248,596
Deferred tax liabilities, net		818				1,855
Other long-term liabilities		10,277				8,262
Long-term debt, net		108,875				63,914
Total liabilities		459,472				394,176
Commitments and contingencies
Equity:
Common stock, $0.001 par value; 100,000 shares authorized; 30,565 and 30,308 shares issued and outstanding, respectively, at September 30, 2024; and 30,297 and 29,948 shares issued and outstanding, respectively, at December 31, 2023		31				29
Additional paid-in capital		117,947				105,712
Retained earnings		51,464				34,663
Treasury stock, at cost, 3 shares at September 30, 2024 and December 31, 2023		(65	)			(65	)
Total The Pennant Group, Inc. stockholders’ equity		169,377				140,339
Noncontrolling interest		17,910				5,176
Total equity		187,287				145,515
Total liabilities and equity	$	646,759			$	539,691

THE PENNANT GROUP, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands)
The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:
	Nine Months Ended September 30,
		2024				2023
Net cash provided by operating activities	$	18,729			$	27,910
Net cash used in investing activities		(66,287	)			(17,576	)
Net cash provided by (used in) financing activities		45,963				(9,030	)
Net (decrease) increase in cash		(1,595	)			1,304
Cash beginning of period		6,059				2,079
Cash end of period	$	4,464			$	3,383

THE PENNANT GROUP, INC. REVENUE BY SEGMENT (unaudited, dollars in thousands)
The following table sets forth our total revenue by segment and as a percentage of total revenue for the periods indicated:
	Three Months Ended September 30,
		2024							2023
	Revenue Dollars				Revenue Percentage			Revenue Dollars				Revenue Percentage
Home health and hospice services
Home health	$	60,988			33.8	%		$	44,921			32.0	%
Hospice		62,757			34.7				50,371			35.9
Home care and other(a)		11,927			6.6				6,182			4.4
Total home health and hospice services		135,672			75.1				101,474			72.3
Senior living services		45,016			24.9				38,718			27.7
Total revenue	$	180,688			100.0	%		$	140,192			100.0	%

(a

)

Home care and other revenue is included with home health revenue in other disclosures in this press release.

	Nine Months Ended September 30,
		2024							2023
	Revenue Dollars				Revenue Percentage			Revenue Dollars				Revenue Percentage
Home health and hospice services
Home health	$	172,773			34.1	%		$	129,112			32.4	%
Hospice		176,711			34.9				140,222			35.1
Home care and other(a)		27,979			5.5				18,239			4.6
Total home health and hospice services		377,463			74.5				287,573			72.1
Senior living services		128,885			25.5				111,364			27.9
Total revenue	$	506,348			100.0	%		$	398,937			100.0	%

(a

)

Home care and other revenue is included with home health revenue in other disclosures in this press release.

THE PENNANT GROUP, INC. SELECT PERFORMANCE INDICATORS (unaudited, total revenue dollars in thousands)
The following table summarizes our overall home health and hospice performance indicators for the each of the dates or periods indicated:
	Three Months Ended September 30,
		2024				2023			Change				% Change
Total agency results:
Home health and hospice revenue	$	135,672			$	101,474				34,198			33.7	%
Home health services:
Total home health admissions		14,993				10,829				4,164			38.5	%
Total Medicare home health admissions		6,071				4,640				1,431			30.8	%
Average Medicare revenue per 60-day completed episode(a)	$	3,760			$	3,480			$	280			8.0	%
Hospice services:
Total hospice admissions		2,987				2,433				554			22.8	%
Average daily census		3,444				2,698				746			27.7	%
Hospice Medicare revenue per day	$	183			$	183			$	—			—	%

	Three Months Ended September 30,
		2024				2023			Change				% Change
Same agency(b) results:
Home health and hospice revenue	$	110,748			$	98,732			$	12,016			12.2	%
Home health services:
Total home health admissions		12,221				10,570				1,651			15.6	%
Total Medicare home health admissions		5,008				4,521				487			10.8	%
Average Medicare revenue per 60-day completed episode(a)	$	3,587			$	3,488			$	99			2.8	%
Hospice services:
Total hospice admissions		2,624				2,351				273			11.6	%
Average daily census		2,995				2,650				345			13.0	%
Hospice Medicare revenue per day	$	184			$	186			$	(2	)		(1.1	)%

	Nine Months Ended September 30,
		2024				2023			Change				% Change
Total agency results:
Home health and hospice revenue	$	377,463			$	287,573			$	89,890			31.3	%
Home health services:
Total home health admissions		43,782				32,180				11,602			36.1	%
Total Medicare home health admissions		18,155				14,437				3,718			25.8	%
Average Medicare revenue per 60-day completed episode(a)	$	3,646			$	3,467			$	179			5.2	%
Hospice services:
Total hospice admissions		9,118				7,206				1,912			26.5	%
Average daily census		3,209				2,544				665			26.1	%
Hospice Medicare revenue per day	$	182			$	184			$	(2	)		(1.1	)%

	Nine Months Ended September 30,
		2024				2023			Change				% Change
Same agency(b) results:
Home health and hospice revenue	$	322,941			$	284,228			$	38,713			13.6	%
Home health services:
Total home health admissions		36,623				31,710				4,913			15.5	%
Total Medicare home health admissions		15,441				14,221				1,220			8.6	%
Average Medicare revenue per 60-day completed episode(a)	$	3,546			$	3,469			$	77			2.2	%
Hospice services:
Total hospice admissions		7,970				7,104				866			12.2	%
Average daily census		2,851				2,528				323			12.8	%
Hospice Medicare revenue per day	$	185			$	186			$	(1	)		(0.5	)%

(a	)	The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.
(b	)	Same agency results represent all agencies purchased or licensed prior to January 1, 2023.

The following table summarizes our senior living performance indicators for the periods indicated:
	Three Months Ended September 30,								Nine Months Ended September 30,
		2024				2023				2024				2023
Total senior living results:
Senior living revenue	$	45,016			$	38,718			$	128,885			$	111,364
Occupancy		79.1	%			78.9	%			78.9	%			78.4	%
Average monthly revenue per occupied unit	$	4,836			$	4,486			$	4,758			$	4,401

	Three Months Ended September 30,								Nine Months Ended September 30,
		2024				2023				2024				2023
Same store senior living(a) results:
Senior living revenue	$	41,030			$	38,126			$	119,625			$	110,225
Occupancy		80.2	%			80.1	%			79.7	%			79.6	%
Average monthly revenue per occupied unit	$	4,790			$	4,454			$	4,724			$	4,380

(a)

Same store senior living results is defined as all senior living communities excluding affiliate memory care units in transition, and new senior living operations acquired in 2023 or 2024.

THE PENNANT GROUP, INC. REVENUE BY PAYOR SOURCE (unaudited, dollars in thousands)
The following table presents our total revenue by payor source as a percentage of total revenue for the periods indicated:
		Three Months Ended September 30,
			2024							2023
		Revenue Dollars				Revenue Percentage			Revenue Dollars				Revenue Percentage
Revenue:
Medicare		$	86,919			48.1	%		$	67,925			48.5	%
Medicaid			22,715			12.6				19,893			14.2
Subtotal			109,634			60.7				87,818			62.7
Managed Care			24,652			13.6				19,158			13.6
Private and Other(a)			46,402			25.7				33,216			23.7
Total revenue		$	180,688			100.0	%		$	140,192			100.0	%

(a)

Private and other payors includes revenue from all payors generated in the Company’s home care operations and management services agreement.

		Nine Months Ended September 30,
			2024							2023
		Revenue Dollars				Revenue Percentage			Revenue Dollars				Revenue Percentage
Revenue:
Medicare		$	245,746			48.5	%		$	192,895			48.3	%
Medicaid			66,386			13.1				56,455			14.2
Subtotal			312,132			61.6				249,350			62.5
Managed Care			66,084			13.1				53,538			13.4
Private and Other(a)			128,132			25.3				96,049			24.1
Total revenue		$	506,348			100.0	%		$	398,937			100.0	%

(a)

Private and other payors includes revenue from all payors generated in the Company’s home care operations and management services agreement.

THE PENNANT GROUP, INC. RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION (unaudited, in thousands, except per share data)
The following table reconciles net income to Non-GAAP net income for the periods presented:
	Three Months Ended September 30,								Nine Months Ended September 30,
		2024				2023				2024				2023
Net income attributable to The Pennant Group, Inc.	$	6,205			$	4,383			$	16,801			$	9,030
Non-GAAP adjustments
Costs at start-up operations(a)		66				59				244				1,060
Share-based compensation expense(b)		2,342				1,391				5,817				4,164
Acquisition related costs and credit allowances(c)		494				71				996				175
Interest expense - write off deferred financing fees(e)		428				—				428				—
Costs associated with transitioning operations(d)		68				90				(418	)			759
Unusual, non-recurring or redundant charges(e)		239				1,009				546				1,633
Provision for income taxes on Non-GAAP adjustments(f)		(1,675	)			(1,031	)			(2,942	)			(1,562	)
Non-GAAP net income	$	8,167			$	5,972			$	21,472			$	15,259
Dilutive Earnings Per Share As Reported
Net Income	$	0.20			$	0.15			$	0.54			$	0.30
Average number of shares outstanding		31,363				30,206				30,869				30,178
Adjusted Diluted Earnings Per Share
Net Income	$	0.26			$	0.20			$	0.70			$	0.51
Average number of shares outstanding		31,363				30,206				30,869				30,178

(a)		Represents results related to start-up operations.
					Three Months Ended September 30,								Nine Months Ended September 30,
						2024				2023				2024				2023
		Revenue			$	—			$	(2,928	)		$	(4,956	)		$	(8,821	)
		Cost of services				65				2,820				4,884				8,981
		Rent				—				162				306				885
		Depreciation & amortization				1				5				10				15
		Total Non-GAAP adjustment			$	66			$	59			$	244			$	1,060
(b)		Represents share-based compensation expense incurred for the periods presented.
					Three Months Ended September 30,								Nine Months Ended September 30,
						2024				2023				2024				2023
		Cost of services			$	1,069			$	819			$	2,814			$	2,288
		General and administrative				1,273				572				3,003				1,876
		Total Non-GAAP adjustment			$	2,342			$	1,391			$	5,817			$	4,164
(c)		Represents costs incurred to acquire an operation that are not capitalizable.

(d)		During the nine months ended September 30, 2023, an affiliate of the Company placed its memory care units into transition and began seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition. The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with an entity transitioned to Ensign.
					Three Months Ended September 30,								Nine Months Ended September 30,
						2024				2023				2024				2023
		Revenue			$	—			$	(4	)		$	(1	)		$	(4	)
		Cost of services				12				14				(582	)			599
		Rent				53				77				157				156
		Depreciation				3				3				8				8
		Total Non-GAAP adjustment			$	68			$	90			$	(418	)		$	759
(e)		Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
(f)		Represents an adjustment to the provision for income tax to the year-to-date effective tax rate of 26.0% and 25.9% for the nine months ended September 30, 2024 and 2023, respectively. This rate excludes the tax benefit of share-based payment awards.

The table below reconciles Consolidated net income to the Consolidated Non-GAAP financial measures, Consolidated Adjusted EBITDA, and to the Non-GAAP valuation measure, Consolidated Adjusted EBITDAR, for the periods presented:
	Three Months Ended September 30,								Nine Months Ended September 30,
		2024				2023				2024				2023
Consolidated net income	$	6,657			$	4,462			$	17,809			$	9,381
Less: Net income attributable to noncontrolling interest		452				79				1,008				351
Add: Provision for income taxes		1,354				1,066				4,957				3,894
Net interest expense		2,892				1,496				6,306				4,355
Depreciation and amortization		1,493				1,323				4,292				3,817
Consolidated EBITDA		11,944				8,268				32,356				21,096
Adjustments to Consolidated EBITDA
Add: Costs at start-up operations(a)		65				(108	)			(72	)			160
Share-based compensation expense(b)		2,342				1,391				5,817				4,164
Acquisition related costs and credit allowances(c)		494				71				996				175
Costs associated with transitioning operations(d)		12				10				(583	)			595
Unusual, non-recurring or redundant charges(e)		239				1,009				546				1,633
Rent related to items (a) and (d) above		53				239				463				1,041
Consolidated Adjusted EBITDA		15,149				10,880				39,523				28,864
Rent—cost of services		10,906				10,006				31,814				29,439
Rent related to items (a) and (d) above		(53	)			(239	)			(463	)			(1,041	)
Adjusted rent—cost of services		10,853				9,767				31,351				28,398
Consolidated Adjusted EBITDAR(f)	$	26,002							$	70,874

(a)		Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations.
(b)		Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense.
(c)		Non-capitalizable costs associated with acquisitions, credit allowances, and write offs for amounts in dispute with the prior owners of certain acquired operations.
(d)		During the nine months ended September 30, 2023, an affiliate of the Company placed its memory care units into transition and began seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition. The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with an entity transitioned to Ensign.
(e)		Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
(f)		This measure is a valuation measure and is displayed thusly, it is not a performance measure as it excludes rent expense, which is a normal and recurring operating expense and, as such, does not reflect our cash requirements for leasing commitments. Our presentation of Consolidated Adjusted EBITDAR should not be construed as a financial performance measure.

The following table present certain financial information regarding our reportable segments. General and administrative expenses are not allocated to the reportable segments and are included in “All Other”:
	Home Health and Hospice Services				Senior Living Services				All Other				Total
Segment GAAP Financial Measures:
Three Months Ended September 30, 2024
Revenue	$	135,672			$	45,016			$	—			$	180,688
Segment Adjusted EBITDAR from Operations	$	23,724			$	13,411			$	(11,133	)		$	26,002
Three Months Ended September 30, 2023
Revenue	$	101,474			$	38,718			$	—			$	140,192
Segment Adjusted EBITDAR from Operations	$	17,271			$	11,473			$	(8,097	)		$	20,647

	Home Health and Hospice Services				Senior Living Services				All Other				Total
Segment GAAP Financial Measures:
Nine Months Ended September 30, 2024
Revenue	$	377,463			$	128,885			$	—			$	506,348
Segment Adjusted EBITDAR from Operations	$	64,488			$	38,226			$	(31,840	)		$	70,874
Nine Months Ended September 30, 2023
Revenue	$	287,573			$	111,364			$	—			$	398,937
Segment Adjusted EBITDAR from Operations	$	47,364			$	33,394			$	(23,496	)		$	57,262

The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to Condensed Consolidated Income from Operations:
	Three Months Ended September 30,								Nine Months Ended September 30,
		2024				2023				2024				2023
Segment Adjusted EBITDAR from Operations(a)	$	26,002			$	20,647			$	70,874			$	57,262
Less: Depreciation and amortization		1,493				1,323				4,292				3,817
Rent—cost of services		10,906				10,006				31,814				29,439
Other income		109				(37	)			192				28
Adjustments to Segment EBITDAR from Operations:
Less: Costs at start-up operations(b)		65				(108	)			(72	)			160
Share-based compensation expense(c)		2,342				1,391				5,817				4,164
Acquisition related costs and credit allowances(d)		494				71				996				175
Costs associated with transitioning operations(e)		12				10				(583	)			595
Unusual, non-recurring or redundant charges(f)		239				1,009				546				1,633
Add: Net income attributable to noncontrolling interest		452				79				1,008				351
Consolidated Income from Operations	$	10,794			$	7,061			$	28,880			$	17,602

(a)		Segment Adjusted EBITDAR from Operations is net income (loss) attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, and, in order to view the operations performance on a comparable basis from period to period, certain adjustments including: (1) costs at start-up operations, (2) share-based compensation, (3) acquisition related costs and credit allowances, (4) the costs associated with transitioning operations, (5) unusual, non-recurring or redundant charges, and (6) net income attributable to noncontrolling interest. General and administrative expenses are not allocated to the reportable segments, and are included as “All Other,” accordingly the segment earnings measure reported is before allocation of corporate general and administrative expenses. The Company's segment measures may be different from the calculation methods used by other companies and, therefore, comparability may be limited.
(b)		Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations.
(c)		Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense.
(d)		Non-capitalizable costs associated with acquisitions, credit allowances, and write offs for amounts in dispute with the prior owners of certain acquired operations.
(e)		During the nine months ended September 30, 2023, an affiliate of the Company placed its memory care units into transition and began seeking to sublease the units to an unrelated third party. The amount above represents the net operating impact attributable to the units in transition. The amounts reported exclude rent and depreciation and amortization expense related to such operations and include legal settlement costs associated with an entity transitioned to Ensign.
(f)		Represents unusual or non-recurring charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.

The tables below reconcile Segment Adjusted EBITDAR from Operations to Segment Adjusted EBITDA from Operations for each reportable segment for the periods presented:
	Three Months Ended September 30,
	Home Health and Hospice								Senior Living
		2024				2023				2024				2023
Segment Adjusted EBITDAR from Operations	$	23,724			$	17,271			$	13,411			$	11,473
Less: Rent—cost of services		1,861				1,439				9,045				8,567
Rent related to start-up and transitioning operations		—				(72	)			(53	)			(167	)
Segment Adjusted EBITDA from Operations	$	21,863			$	15,904			$	4,419			$	3,073

	Nine Months Ended September 30,
	Home Health and Hospice								Senior Living
		2024				2023				2024				2023
Segment Adjusted EBITDAR from Operations	$	64,488			$	47,364			$	38,226			$	33,394
Less: Rent—cost of services		5,254				4,136				26,560				25,303
Rent related to start-up and transitioning operations		(122	)			(248	)			(341	)			(793	)
Segment Adjusted EBITDA from Operations	$	59,356			$	43,476			$	12,007			$	8,884

Discussion of Non-GAAP Financial Measures

EBITDA consists of net income before (a) interest expense, net, (b) (benefits) provisions for income taxes, and (c) depreciation and amortization. Adjusted EBITDA consists of net income attributable to the Company before (a) interest expense, net (b) (benefits) provisions for income taxes, (c) depreciation and amortization, (d) costs incurred for start-up operations, including rent and excluding depreciation, interest and income taxes, (e) share-based compensation expense, (f) non-capitalizable acquisition related costs and credit allowances, (g) net costs associated with transitioning operations, (h) unusual, non-recurring or redundant charges and (i) net income attributable to noncontrolling interest. Consolidated Adjusted EBITDAR is a valuation measure applicable to current periods only and consists of net income attributable to the Company before (a) interest expense, net, (b) (benefits) provisions for income taxes, (c) depreciation and amortization, (d) rent-cost of services, (e) costs incurred for start-up operations, excluding rent, depreciation, interest and income taxes, (f) share-based compensation expense, (g) acquisition related costs and credit allowances, (h) redundant or non-recurring transition services costs, (i) costs associated with transitioning operations, (j) unusual, non-recurring or redundant charges and (j) net income attributable to noncontrolling interest. The company believes that the presentation of EBITDA, adjusted EBITDA, consolidated adjusted EBITDAR, adjusted net income and adjusted earnings per share provides important supplemental information to management and investors to evaluate the company’s operating performance. The company believes disclosure of adjusted net income, adjusted net income per share, EBITDA, adjusted EBITDA and consolidated adjusted EBITDAR has economic substance because the excluded revenues and expenses are infrequent in nature and are variable in nature, or do not represent current revenues or cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the company believes that this non-GAAP measure provides useful information to investors, the specific manner in which management uses this measure, and some of the limitations associated with the use of this measure, please refer to the company's periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The company’s periodic filings are available on the SEC's website at www.sec.gov or under the "Financial Information" link of the Investor Relations section on Pennant’s website at http://www.pennantgroup.com.

FAQ

What was Pennant Group's (PNTG) revenue in Q3 2024?

Pennant Group reported total revenue of $180.7 million in Q3 2024, representing a 28.9% increase from the previous year.

What is Pennant Group's (PNTG) earnings guidance for 2024?

Pennant Group expects adjusted earnings per diluted share between $0.90 and $0.96 for full year 2024.

How much did Pennant Group's (PNTG) home health admissions grow in Q3 2024?

Total home health admissions grew by 38.5% to 14,993 in Q3 2024 compared to the prior year quarter.